New diabetes pill shows promise for patients failing ozempic
NCT ID NCT07502508
First seen Apr 15, 2026 · Last updated May 19, 2026 · Updated 6 times
Summary
This study tests a new daily pill, icovamenib, for people with type 2 diabetes whose blood sugar is still too high despite using Ozempic. About 60 adults will receive either the study drug or a placebo for 12 weeks. The main goal is to see if icovamenib lowers HbA1c (a measure of blood sugar control) better than placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ark Clinical Research
RECRUITINGLong Beach, California, 90815, United States
-
Burke Internal Medicine and Research
RECRUITINGBurke, Virginia, 22015, United States
-
Catalina Research Institute, LLC
RECRUITINGMontclair, California, 91763, United States
-
Central Research Associates, LLC dba Flourish Research
RECRUITINGBirmingham, Alabama, 35205, United States
-
David Kavtaradze MD, Inc
RECRUITINGCordele, Georgia, 31015, United States
-
Diabetes & Glandular Disease Clinic, P.A.
RECRUITINGSan Antonio, Texas, 78229, United States
-
Diabetes and Endocrinology Associates of Stark County
RECRUITINGCanton, Ohio, 44718, United States
-
Elligo Health Research, Inc.
RECRUITINGAustin, Texas, 78704, United States
-
Epic Clinical Research
RECRUITINGLewisville, Texas, 75057, United States
-
Excel Clinical Research
RECRUITINGLas Vegas, Nevada, 89109, United States
-
Hope Clinical Research
RECRUITINGCanoga Park, California, 91303, United States
-
Panax Clinical Research
RECRUITINGMiami Lakes, Florida, 33014, United States
-
Paradigm Clinical Research Centers, LLC
RECRUITINGSan Diego, California, 92108, United States
-
Southwest General Healthcare Center
RECRUITINGFort Myers, Florida, 33907, United States
-
Synergy Group Medical
RECRUITINGHouston, Texas, 77061, United States
-
Zenos Clinical Research
RECRUITINGDallas, Texas, 75230, United States
Conditions
Explore the condition pages connected to this study.